CHU Sainte-Justine Research Center, University of Montreal, Montreal, Quebec, Canada.
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
Clin Genet. 2021 Nov;100(5):607-614. doi: 10.1111/cge.14033. Epub 2021 Jul 29.
Early infantile epileptic encephalopathy 38 (EIEE38, MIM #617020) is caused by biallelic variants in ARV1, encoding a transmembrane protein of the endoplasmic reticulum with a pivotal role in glycosylphosphatidylinositol (GPI) biosynthesis. We ascertained seven new patients from six unrelated families harboring biallelic variants in ARV1, including five novel variants. Affected individuals showed psychomotor delay, hypotonia, early onset refractory seizures followed by regression and specific neuroimaging features. Flow cytometric analysis on patient fibroblasts showed a decrease in GPI-anchored proteins on the cell surface, supporting a lower residual activity of the mutant ARV1 as compared to the wildtype. A rescue assay through the transduction of lentivirus expressing wild type ARV1 cDNA effectively rescued these alterations. This study expands the clinical and molecular spectrum of the ARV1-related encephalopathy, confirming the essential role of ARV1 in GPI biosynthesis and brain function.
早发性婴儿癫痫性脑病 38 型(EIEE38,MIM #617020)是由 ARV1 的双等位基因突变引起的,该基因编码内质网膜的跨膜蛋白,在糖基磷脂酰肌醇(GPI)生物合成中起关键作用。我们从六个无关联的家庭中确定了七个新的患者,他们均携带 ARV1 的双等位基因突变,包括五个新的变异。受影响的个体表现为精神运动发育迟缓、张力减退、早期发作的难治性癫痫,随后出现退行性改变和特定的神经影像学特征。对患者成纤维细胞的流式细胞分析显示,细胞表面的 GPI 锚定蛋白减少,表明与野生型相比,突变型 ARV1 的残余活性较低。通过转导表达野生型 ARV1 cDNA 的慢病毒进行的挽救实验有效地挽救了这些改变。本研究扩展了 ARV1 相关脑病的临床和分子谱,证实了 ARV1 在 GPI 生物合成和大脑功能中的重要作用。